Skip to main content
. Author manuscript; available in PMC: 2015 Nov 1.
Published in final edited form as: Cancer Chemother Pharmacol. 2014 Oct 28;75(1):59–66. doi: 10.1007/s00280-014-2613-7

Fig. 3.

Fig. 3

(A) Course of WBC following HD-MTX in relation to coadministered 6MP dose The course is conditional on an observed WBC value of 2.5 ×109/L at the day of administration of HD-MTX. P value for test of no difference between curves: P<0.001.

(B) Course of ANC following HD-MTX in relation to coadministered 6MP dose The course is conditional on an observed ANC value of 1.5 ×109/L at the day of administration of HD-MTX. P value for test of no difference between curves: P<0.001.